{"altmetric_id":15781165,"counts":{"readers":{"mendeley":4,"citeulike":0,"connotea":0},"total":{"posts_count":1},"policy":{"unique_users_count":1,"unique_users":["nice"],"posts_count":1}},"citation":{"altmetric_jid":"4f6fa62a3cf058f610007e94","authors":["Denis Malvy","Claude Maingourd","Josette Pengloan","Philippe Bagros","Hubert Nivet"],"doi":"10.1080\/07315724.1999.10718887","endpage":"486","first_seen_on":"2017-01-25T14:35:58+00:00","issns":["0731-5724","1541-1087"],"issue":"5","journal":"The Journal of the American College of Nutrition","last_mentioned_on":1363132800,"links":["http:\/\/dx.doi.org\/10.1080\/07315724.1999.10718887"],"pubdate":"1999-10-01T00:00:00+00:00","publisher_subjects":[{"name":"Nutrition And Dietetics","scheme":"era"}],"scopus_subjects":["Medicine","Health Sciences","Nursing"],"startpage":"481","title":"Effects of Severe Protein Restriction with Ketoanalogues in Advanced Renal Failure","type":"article","uri":"http:\/\/www.tandfonline.com\/doi\/abs\/10.1080\/07315724.1999.10718887","volume":"18","mendeley_url":"http:\/\/www.mendeley.com\/research\/effects-severe-protein-restriction-ketoanalogues-advanced-renal-failure"},"altmetric_score":{"score":3,"score_history":{"1y":0,"6m":0,"3m":0,"1m":0,"1w":0,"6d":0,"5d":0,"4d":0,"3d":0,"2d":0,"1d":0,"at":3},"context_for_score":{"all":{"total_number_of_other_articles":7030920,"mean":6.2656066980691,"rank":1650699,"this_scored_higher_than_pct":64,"this_scored_higher_than":4555436,"rank_type":"exact","sample_size":7030920,"percentile":64},"similar_age_3m":{"total_number_of_other_articles":89047,"mean":11.134921568628,"rank":27001,"this_scored_higher_than_pct":67,"this_scored_higher_than":60489,"rank_type":"exact","sample_size":89047,"percentile":67},"this_journal":{"total_number_of_other_articles":884,"mean":13.565155152888,"rank":369,"this_scored_higher_than_pct":37,"this_scored_higher_than":333,"rank_type":"exact","sample_size":884,"percentile":37},"similar_age_this_journal_3m":{"total_number_of_other_articles":4,"mean":1.7833333333333,"rank":2,"this_scored_higher_than_pct":50,"this_scored_higher_than":2,"rank_type":"exact","sample_size":4,"percentile":50}}},"demographics":{"users":{"mendeley":{"by_status":{"Student  > Ph. D. Student":1,"Student  > Master":1,"Other":1,"Lecturer":1},"by_discipline":{"Medicine and Dentistry":3,"Nursing and Health Professions":1}}},"geo":{"mendeley":{"IT":1}}},"posts":{"policy":[{"title":"Chronic kidney disease (stage 4 or 5): management of hyperphosphataemia: Appendix E - evidence tables and GRADE profiles","url":"https:\/\/www.nice.org.uk\/guidance\/cg157\/evidence\/appendix-e-evidence-tables-and-grade-profiles-189805649","license":"public","citation_ids":[15781019,2414669,15779246,512477,4112125,5365329,15779260,15781024,15781030,15781033,15781039,211250,15781056,20589299,15781058,15781062,6285980,15781065,15779256,1449361,15781076,15781082,15781086,15781088,15781090,15781093,15779275,15781101,4734290,15781106,15779268,5391920,15781114,15779281,15779284,15781122,15781125,1263466,15779226,20589305,15781132,15781136,8208371,15781145,15779233,4578704,15781157,14987899,1940960,15781165,15781170,15781173,192526,15781175,15781177,15779285,15781180],"posted_on":"2013-03-13T00:00:00+00:00","source":{"name":"National Institute for Health and Care Excellence","description":"The National Institute for Health and Care Excellence (NICE) in the UK provides national guidance and advice to improve health and social care.","geo":{"country":"GB"}},"page_url":"https:\/\/www.nice.org.uk\/guidance\/cg157\/evidence","collections":[],"author":{"image":"https:\/\/s3.amazonaws.com\/cache.altmetric.com\/policy\/thumbnails\/thumbnail-b99926d49d2e5b52d6fb4553876651dd742d017a80728b26ca0ad162c1cf27b3.jpg"}}]}}